Results 121 to 130 of about 101,889 (202)

A real-world assessment of mycophenolate mofetil for remission induction in eosinophilic granulomatosis with polyangiitis. [PDF]

Rheumatol Int, 2021
Philobos M, Perkins A, Karabayas M, Dospinescu P, Fluck N, Kidder D, Chapman FA, Dhaun N, Basu N.   +8 more
europepmc   +1 more source

Efficacy and safety of advanced therapies for moderately to severely active ulcerative colitis in induction and maintenance: systematic literature review and Bayesian network meta-analysis

Journal of Comparative Effectiveness Research
Aim: Several therapies have recently been licensed for the treatment of patients with moderately to severely active ulcerative colitis (UC). To provide comparative evidence of newly available treatments, Bayesian network meta-analyses were conducted to
Vipul Jairath, Tim Raine, Thomas P Leahy, Ravi Potluri, Karolina Wosik, David Grube, Joseph C Cappelleri, Peter Hur, Lauren Bartolome   +8 more
doaj   +1 more source

Prognostic Observational Analysis of BMI, Leptin, and Adiponectin in Children With Acute Lymphocytic Leukemia Undergoing Remission-Induction Chemotherapy. [PDF]

Front Pediatr, 2022
Sun J, Zhang R, Tang J, Wu X, Zhu L, Huang H, Chen H, Xiao M, Luo H, Zheng H, Chen J.   +10 more
europepmc   +1 more source

Peripherally inserted central venous catheters for remission induction chemotherapy phase of acute leukemia: a single center experience in severely thrombocytopenic patients. [PDF]

Ann Hematol
Picardi M, Giordano C, Vincenzi A, Scarpa A, Pugliese N, Della Pepa R, Cimmino E, Persico M, Pane F.   +8 more
europepmc   +1 more source

Association of leukocyte nadir with complete remission in Indonesian acute myeloid leukemia patients undergoing 7+3 remission induction chemotherapy. [PDF]

F1000Res, 2022
Hadisantoso DW, Ranuhardy D, Rajabto W, Rizka A, Setiawan L, Rinaldi I, Mansjoer A, Nelwan EJ, Shatri H.   +8 more
europepmc   +1 more source

Tissue-invasive CMV disease is associated with poor prognosis during remission induction therapy for autoimmune inflammatory rheumatic diseases. [PDF]

Front Immunol
Oka H, Sumitomo S, Miyakoshi C, Ohmura K.   +3 more
europepmc   +1 more source

Intravascular Complications of Central Venous Catheterization by Insertion Site in Acute Leukemia during Remission Induction Chemotherapy Phase: Lower Risk with Peripherally Inserted Catheters in a Single-Center Retrospective Study. [PDF]

Cancers (Basel), 2023
Picardi M, Giordano C, Della Pepa R, Pugliese N, Esposito M, Abagnale DP, Giannattasio ML, Lisi D, Lamagna M, Grimaldi F, Muccioli Casadei G, Ciriello M, Persico M, Gargiulo G, Pane F.   +14 more
europepmc   +1 more source

Remission induction in refractory, drug resistant pediatric PICALM::MLLT10+ B-cell acute lymphoblastic leukemia by venetoclax. [PDF]

Leukemia
Niedermayer A, Stursberg J, Bergmann AK, Zimmermann M, Cario G, Brüggemann M, Köhler R, Steinbach D, Reimann C, Seyfried F, Meyer LH, Debatin KM.   +11 more
europepmc   +1 more source

Reduced Dose Intensity of Daunorubicin During Remission Induction for Low-Risk Patients With Acute Lymphoblastic Leukemia: A Retrospective Cohort Study of the Chinese Children's Cancer Group. [PDF]

Front Oncol, 2022
Zhuang Y, Wu K, Zhu X, Cai J, Hu S, Gao J, Jiang H, Zhai X, Tian X, Fang Y, Jin R, Hu Q, Jiang H, Wang N, Sun L, Leung WK, Yang M, Pan K, Wu X, Liang C, Shen S, Yu J, Ju X.   +22 more
europepmc   +1 more source

Is Mesalamine Effective for the Induction of Remission in Crohnʼs Disease? [PDF]

Inflammatory Bowel Diseases, 2017
Bonovas S, Peyrin-Biroulet L, Danese S
openaire   +3 more sources